Register for updates, request contact from a sales rep or Medical Science Liaison, or request medical, reimbursement, or clinical trials information. REQUEST INFORMATION Get reimbursement support and assistance with CORE: Cephalon Oncology Reimbursement Expertise. REIMBURSEMENT Find summaries and links for marketed products including TREANDA® (bendamustine HCI) for injection. PRODUCTS Patients are currently being recruited in the following clinical trials: CEP-701 trials A Randomized, Open Label Study of Oral CEP 701 Administered in Sequence With Standard Chemotherapy to Patients With Relapsed Acute Myeloid Leukemia (AML) Expressing FLT 3 Activating Mutations. Open-Label Study of Oral CEP-701 (lestaurtinib) in Patients With Polycythemia Vera or Essential Thrombocytosis. Arsenic Trioxide Study of Low-Dose Cytarabine in Combination With Arsenic Trioxide, Compared With Low-Dose Cytarabine Alone, for the Treatment of Elderly Patients With Acute Myeloid Leukemia (AML). Information about other ongoing clinical research studies may also be found at www.clinicaltrials.gov. Investigator Sponsored Studies Program Submit your own clinical study proposal to become an investigator with Cephalon Oncology. Learn more at www.CephalonOncologyISSP.com. External Resources Clinical Trials Centerwatch NIH Clinical Trials Listing WebMD In The News  •  Privacy  •  Terms of Use SITE MAP     CONTACT US     CEPHALON.COM ©2009 Cephalon, Inc. All rights reserved. The information presented on this site is intended for U.S. residents only.